Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-02-01
DOI
https://doi.org/10.1136/jitc-2024-010291
Citations
9
Primary Topic
Viral-associated cancers and disorders
Type
article
Field-Weighted Citation Impact
9.41

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma

Leonard D’Amico, Angela Shaulov Kask, Byung Ha Lee, Martin A. Cheever et al.
9 citations
Journal for ImmunoTherapy of Cancer
Viral-associated cancers and disorders
9.41
article

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma

Leonard D’Amico, Angela Shaulov Kask, Byung Ha Lee, Martin A. Cheever, Judith C. Kaiser, Li‐Lian Kwok, Kathryn Lurain, Steven P. Fling, Anna K. Wright, Paul Couey, Robert Yarchoan, Thomas S. Uldrick, Ellen Lyda Burnham, Chia-Ching Jackie Wang, Ramya Ramaswami, Irene Ekwede, Manoj Menon, Allysson Angeldekao
article en
9 citations

Abstract

No abstract available for this paper.
Journal for ImmunoTherapy of CancerVol. 13(2)
University of California, San Francisco (US), Harborview Medical Center (US), Fred Hutch Cancer Center (US), National Cancer Institute (US), UCSF Helen Diller Family Comprehensive Cancer Center (US)
National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 2%
Viral-associated cancers and disorders
9.41
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.